NVS
Novartis AG ADR
Novartis AG ADR historical holders
total: 9
Cullen Value Fund Novartis AG ADR transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2019 Q3
- Held for:
- 10 quarters
- Latest activity:
- 2022 Q1
Jim Cullen has been an institutional investor in Novartis AG ADR (NVS) since 2019 Q3. According to 2026 Q1 report, Jim Cullen doesn't hold any shares. The fund/company first acquired NVS in 2019 Q3, initially purchasing 9,600 shares. Since the initial investment, Cullen Value Fund has made 2 more transactions in this position.
When did Jim Cullen exit their NVS position?
Jim Cullen no longer holds Novartis AG ADR (NVS). They sold off their entire position in 2022 Q1, closing out an investment that began in 2019 Q3.
When did Jim Cullen first invest in NVS?
Jim Cullen first invested in Novartis AG ADR (NVS) in 2019 Q3 at the reported quarter-end price of $86.90 per share, acquiring 9,600 shares in their initial purchase.
What is Jim Cullen's average cost basis for NVS?
Based on historical transaction data, Jim Cullen's estimated cost basis for Novartis AG ADR (NVS) is approximately $86.90 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $86.90
- Weighted AVG sell price:
- $88.58
NVS transactions history by Cullen Value Fund
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.